Ming Tsao
机构: University of Toronto, University Health Network, Princess Margaret Cancer Centre
每年引用次数
引用次数
引用: 111,772
H-指数: 147
I10-指数 : 605
出版物: 1,205
Drug resistance in cultured rat liver epithelial cells spontaneously and chemically transformed.
Annie Woo , Tsao Ming-Sound , Gerald Batist
Carcinogenesis 13 ( 9) 1675 -1677
7
1992
Abstract B45: Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell and patient-derived tumor organoids
Ling Huang , Audrey Holtzinger , Ishaan Jagan , Cristina Nostro
Cancer Research 76
3
2016
Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours
Helen J. Mackay , Hal Hirte , Terrence Colgan , Al Covens
European Journal of Cancer 46 ( 9) 1573 -1579
102
2010
Lung cancer screening with low-dose computed tomography: Canadian experience.
Igor Sitartchouk , Hamid Bayanati , Frances A Shepherd , Demetris Patsios
Canadian Association of Radiologists journal 58 ( 4) 225 -235
43
2007
A phase II trial of the histone deacetylase inhibitor Belinostat (PXD101) in patients with platinum resistant epithelial ovarian tumors and micropapillary/borderline (LMP) ovarian tumors. A trial of the PMH Phase II Consortium
Hal Hirte , Ming Tsao , Helen Mackay , Amit Oza
Molecular Cancer Therapeutics 6
4
2007
The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification
PAN-CHYR YANG ,
Journal of Thoracic Oncology 4 ( 9)
76
2009
Bcl-B expression in human epithelial and non-epithelial malignancies.
Andrzej Badzio , Aaron Schimmer , Jacek Jassem , Ivo Meinhold-Heerlein
Cancer Research 68 2180 -2180
66
2008
Abstract B50: A phase I study of various administration schedules for RO4929097 (R) with multi-parameter assessment (pharmacokinetics [PK] and primary tumor xenograft [XG]) in patients (pts) with advanced solid cancers.
Albiruni RA Razak , Philippe L. Bedard , Benoit You , Devang Panchal
Molecular Cancer Therapeutics 10
2011
Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer
Helen J. Mackay , Elizabeth A. Eisenhauer , Suzanne Kamel-Reid , Ming Tsao
Cancer 120 ( 4) 603 -610
49
2014
Tumor-Initiating Cells Are Rare in Many Human Tumors
Kota Ishizawa , Zeshaan A. Rasheed , Robert Karisch , Qiuju Wang
Cell Stem Cell 7 ( 3) 279 -282
177
2010
Structure of Collagen in Lung Carcinoma Tissue Characterized with Harmonic Polarization Microscopy
Ahmad Golaraei , Richard Cisek , Roya Navab , Carolyn Niu
Biomedical optics
2014
A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2‐Positive Metastatic Breast Cancer (CCTG IND.229)
Stephen Chia , Phillipe L Bedard , John Hilton , Eitan Amir
Oncologist 24 ( 11) 1439 -1445
36
2019
P-129 Gene expression profiles of developmental stages of non-small cell lung carcinoma
Kim Marie Lonergan , Ashleen Shadeo , Jin-Hee Kim , Bryan Chi
Lung Cancer 41
1
2003
P-303 Construction of a high resolution CGH array for chromosome 5p and analysis of SCLC and NSCLC cell lines
Bradley P. Coe , Cathie Garnis , ChangQi Zhu , Martin Krzywinski
Lung Cancer 41
2003
Phase I Combination of Sorafenib and Erlotinib Therapy in Solid Tumors: Safety, Pharmacokinetic, and Pharmacodynamic Evaluation from an Expansion Cohort
Miguel Quintela-Fandino , Christophe Le Tourneau , Ignacio Duran , Eric X. Chen
Molecular Cancer Therapeutics 9 ( 3) 751 -760
18
2010
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D Travis , Elisabeth Brambilla , Masayuki Noguchi , Andrew G Nicholson
Journal of Thoracic Oncology 6 ( 2) 244 -285
5,395
2011
CMET-30. COMPREHENSIVE METHYLOME ANALYSIS OF EGFR-MUTANT PRIMARY LUNG ADENOCARCINOMA AND MATCHED BRAIN METASTASIS
Yasin Mamatjan , Michael Cabanero , Jeffrey Zuccato , Jessica Weiss
Neuro-oncology 21
2019
BIOM-02. IDENTIFYING MGMT ALTERATIONS AS BIOMARKERS OF SURVIVAL IN LUNG ADENOCARCINOMA WITH BRAIN METASTASES
Yasin Mamatjan , Jeffrey Zuccato , Fabio Moraes , Michael Cabanero
Neuro-oncology 22
2020
Developing a methodology for three-dimensional correlation of PET–CT images and whole-mount histopathology in non-small-cell lung cancer
Yee C. Ung , Max Dahele , David Hwang , Chris Peressotti
Current Oncology 15 ( 5) 62 -69
37
2008
Sequence Dependence of MEK Inhibitor AZD6244 Combined with Gemcitabine for the Treatment of Biliary Cancer
Junyao Xu , Jennifer J. Knox , Emin Ibrahimov , Eric Chen
Clinical Cancer Research 19 ( 1) 118 -127
20
2013